1254163-81-9 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 6-chloro-5-cyanopicolinate is used as an intermediate in the synthesis of various pharmaceutical products for its potential biological activity. It contributes to the development of new drugs by providing a versatile building block for complex organic compound synthesis.
Used in Agricultural Industry:
Methyl 6-chloro-5-cyanopicolinate is used as an intermediate in the synthesis of agrochemicals, particularly for its potential use in developing new pesticides or other agricultural chemicals. Its strong cyanide group and chlorine substituent make it a valuable component in creating effective and targeted agrochemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1254163-81-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,5,4,1,6 and 3 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1254163-81:
(9*1)+(8*2)+(7*5)+(6*4)+(5*1)+(4*6)+(3*3)+(2*8)+(1*1)=139
139 % 10 = 9
So 1254163-81-9 is a valid CAS Registry Number.
1254163-81-9Relevant articles and documents
IMIDAZOLE DERIVATIVES AND THEIR USE AS MODULATORS OF CYCLIN DEPENDENT KINASES
-
Page/Page column 256-257, (2010/11/17)
The invention provides compounds of the formula (I): and salts, tautomers, solvates and N-oxides thereof; wherein Q is CH or N; X is N, N+-O- or CR3; Y is N, N+-O- or CR3a; R1 and R2 are independently selected from hydrogen and various substituents as defined in the claims; or R1 and R2 together with the atoms to which they are attached, link to form an optionally substituted carbocyclic or heterocyclic aromatic or non-aromatic ring of 4 to 7 members; R3 is selected from hydrogen and various substituents; and R3a is selected from hydrogen and various substituents as defined in the claims. Also provided are pharmaceutical compositions containing the compounds of formula (I), processes for making the compounds and the medical uses of the compounds. The compounds of formula (I) have activity as inhibitors of CDK kinases and are useful in the treatment of inter alia proliferative diseases such as cancers.
